Aspirin prophylaxis for vascular disease

Adding the findings of the Swedish Angina Pectoris Aspirin Trial 5 (published after the analyses of the Antiplatelet Trialists' Collaboration) has offered a firmer basis from which to derive recommendations for practice and permitted clear recommendations on the dose of aspirin that is effectiv...

Full description

Saved in:
Bibliographic Details
Published in:BMJ 1998-11, Vol.317 (7168), p.1318-1319
Main Authors: Fitzmaurice, D., Thomas, C. P., Chant, Harvey, Fearn, Shirley, McCollum, Charles, Eccles, Martin, Freemantle, Nick, Mason, James
Format: Article
Language:English
Subjects:
Angina pectoris
Aspirin
Carotid endarterectomy
Collaboration
General practice
Group development
Heart attacks
Letters
Myocardial infarction
Primary health care
Recommendations
Research fellowships
Stable angina
Strokes
Vascular diseases
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Adding the findings of the Swedish Angina Pectoris Aspirin Trial 5 (published after the analyses of the Antiplatelet Trialists' Collaboration) has offered a firmer basis from which to derive recommendations for practice and permitted clear recommendations on the dose of aspirin that is effective.
ISSN:0959-8138
1468-5833
1756-1833
DOI:10.1136/bmj.317.7168.1318a